Phase II placebo-controlled study of nepafenac ophthalmic suspension 0.1% for postoperative inflammation and ocular pain associated with cataract surgery in Japanese patients

OBJECTIVE: This study aimed to examine the efficacy and safety of nepafenac ophthalmic suspension compared to placebo in the management of postoperative inflammation and ocular pain in Japanese patients undergoing cataract surgery. METHODS: This was a multicenter, randomized, double-masked, placebo-...

Descripción completa

Detalles Bibliográficos
Autor principal: Numaga, Jiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2011
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3223346/
https://www.ncbi.nlm.nih.gov/pubmed/21932014
http://dx.doi.org/10.1007/s12348-011-0036-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3223346/
https://www.ncbi.nlm.nih.gov/pubmed/21932014
http://dx.doi.org/10.1007/s12348-011-0036-8

Ejemplares similares